Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. Catalent Inc.
  3. News

Catalent Inc.

  • Overview
  • Financial
  • In Reports
  • Products
  • News

In News

GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent - BioSpace

BioSpace - Jun 26, 2025

GenSight Biologics to Partner with Catalent on Gene Therapy Candidate - CHEManager

CHEManager - Jul 02, 2025

Novo Holdings Completes Acquisition of Catalent - Business Wire

Business Wire - Dec 18, 2024

Novo Holdings completes $16.5B acquisition of Catalent - Inside INdiana Business

Inside INdiana Business - Dec 18, 2024

Gene Therapy Manufacturing Breakthrough: GenSight and Catalent's Path to Rare Disease Commercialization - AInvest

AInvest - Jun 26, 2025

Novo Holdings’ purchase of Catalent set to close after regulators’ green light - BioPharma Dive

BioPharma Dive - Dec 16, 2024

Jupiter Neurosciences, Catalent Partner to Produce JOTROL Softgels for Upcoming Trial - Contract Pharma

Contract Pharma - Mar 18, 2025

Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval - Reuters

Reuters - Dec 06, 2024

Catalent Inc. Reports Q1 Fiscal 2025 Results - Nasdaq

Nasdaq - Nov 05, 2024

Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal - Fierce Pharma

Fierce Pharma - Oct 18, 2024

Catalent, Inc. Reports First Quarter Fiscal 2025 Results - Business Wire

Business Wire - Nov 05, 2024

Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’ - BioSpace

BioSpace - Oct 24, 2024

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All